OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹34 Cr | ₹33 Cr | ₹8.07 Cr | ₹17 Cr | ₹16 Cr |
What is the latest Total Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹34 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹8.07 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹16 Cr |
How is Total Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹34 Cr | 2.42 | |
Mar2023 | ₹33 Cr | 307.76 | |
Mar2022 | ₹8.07 Cr | -53.89 | |
Mar2021 | ₹17 Cr | 10.41 | |
Mar2020 | ₹16 Cr | - |
Compare Total Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹251.6 Cr | -4.2% | -7.9% | 19.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | -2% | 2% | -16.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -5% | -6.6% | 5.9% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | -2.4% | -5.4% | -8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | -0.4% | 0.5% | 5.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -5.8% | -4.4% | -8.4% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -4.2% |
-7.9% |
19.3% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses